Rabies

Vaccines for Biodefense and Emerging and Neglected Diseases

Volumn , Issue , 2009, Pages 609-630

  Fooks, Anthony R ^a   Johnson, Nicholas ^a   Rupprecht, Charles E ^b  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859445216     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369408-9.00033-0     Document Type: Chapter

References (156)

1. Arai Y.T., Kuzmin I.V., Kameoka Y., Botvinkin A.D. New Lyssavirus genotype from the lesser mouse-eared bat ( Myotis blythi), Kyrghyzstan. Emerg. Infect. Dis. 2003, 9(3):1-9.
2. Arguin P.M., Murray-Lillibridge K., Miranda M.E., Smith J.S., Calaor A.B., Rupprecht C.E. Serologic evidence of Lyssavirus infections among bats, the Philippines. Emerg. Infect. Dis. 2002, 8:258-262.
3. Badrane H., Bahloul C., Perrin P., Tordo N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 2001, 75:3268-3276.
4. Baer G.M., Abelseth M.K., Debbie J.G. Oral vaccination of foxes against rabies. Am. J. Epidemiol. 1971, 93:487-490.
5. Bahloul L., Lafon M. Apoptosis and rabies virus neuroinvasion. Biochimie 2003, 85:777-788.
6. Benmansour A., Brahimi M., Tuffereau C., Coulon P., Lafay F., Flamand A. Rapid sequence evolution of street rabies glycoprotein is related to the highly heterogeneous nature of the viral population. Virology 1992, 187:33-45.
7. Blaisdell J.D. The deadly bite of ancient animals: written evidence for rabies, or the lack thereof, in the ancient Egyptian and Mesopotamian texts. Vet. Hist. 1994, 8:22-28.
8. Blanton J.D., Krebs J.W., Hanlon C.A., Rupprecht C.E. Rabies surveillance in the United States during 2005. J. Am. Vet. Med. Assoc. 2006, 229:1897-1911.
9. Botvinkin A.D., Poleschuk E.M., Kuzmin I.V., Borisova T.I., Gazaryan S.V., Yager P., Rupprecht C.E. Novel lyssaviruses isolated from bats in Russia. Emerg. Infect. Dis. 2003, 9:1623-1625.
10. Bourhy H., Dacheux L., Strady C., Mailles A. Rabies in Europe in 2005. Eurosurveillance 2005, 10(11):213-216.
11. Bourhy H., Kissi B., Audry L., Smreczak M., Sadkowska-Todys M., Kulonen K., Tordo N., Zmudzinski J.F., Holmes E.C. Ecology and evolution of rabies virus in Europe. J. Gen. Virol. 1999, 80:2545-2557.
12. Bourhy H., Kissi B., Lafon M., Sacramento D., Tordo N. Antigenic and molecular characterization of bat rabies virus in Europe. J. Clin. Microbiol. 1992, 30:2419-2426.
13. Bourhy H., Kissi B., Tordo N. Molecular diversity of the Lyssavirus genus. Virology 1993, 194:70-81.
14. Brookes S.M., Parsons G., Johnson N., McElhinney L.M., Fooks A.R. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 2005, 23(32):4101-4109.
15. Celis E., Larson J., Otvos L., Wunner W.H. Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4). J. Immunol. 1990, 145:305-310.
16. Celis E., Miller R.W., Wiktor T.J., Dietzshold B., Koprowski H. Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen-specificity and production of interferon-gamma. J. Immunol. 1986, 136:692-697.
17. Cho S.N., Nahara S., Mifune K., Kawai A. Murine T cell clones directed to rabies virus: isolation and some of their properties. J. Gen. Virol. 1987, 68:1115-1123.
18. Constantine D.G. Rabies transmission by the non-bite route. Public Health Rep. 1962, 77:287.
19. Constantine D.G. Geographic translocation of bats: known and potential problems. Emerg. Infect. Dis. 2003, 9:17-21.
20. Constantine D.G., Emmons R.W., Woodie J.D. Rabies virus in nasal mucosa of naturally infected bats. Science 1972, 175:1255-1256.
21. Constantine D.G., Tierkel E.S., Kleckner M.D., Hawkins D.M. Rabies in New Mexico cavern bats. Public Health Rep. 1968, 83:303-316.
22. Crepin P., Audry L., Rotivel Y., Gacoin A., Caroff C., Bourhy H. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J. Clin. Microbiol. 1998, 36:1117-1121.
23. Crick J., King A. Culture of rabies virus in vitro. Rabies 1988, 47-66. Kluwer Academic, Boston, MA. J.B. Campbell, K.M. Charlton (Eds.).
24. Daoust P.Y., Wandeler A.I., Casey G.A. Cluster of rabies cases of probable bat origin among red foxes in Prince Edward Island, Canada. J. Wildl. Dis. 1996, 32(2):403-406.
25. Dean D.J., Abelseth M.K., Atanasiu P. The fluorescent antibody test. Laboratory Techniques in Rabies 1996, 88-93. World Health Organization, Geneva. 4th ed. F.-X. Meslin, M.M. Kaplan, H. Kowprowski (Eds.).
26. Desmezieres E., Jacob Y., Saron M.F., Delpeyroux F., Tordo N., Perrin P. Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines. J. Gen. Virol. 1999, 80:2343-2351.
27. Dietzschold B., Gore M., Marchadier D., Niu H.S., Bunschoten H.M., Otvos L., Wunner W.H., Ertl H.C.J., Osterhaus A.D.M.E., Koprowski H. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J. Virol. 1990, 64:3804-3809.
28. Dietzschold B., Morimoto K., Hooper D.C., Smith J.S., Rupprecht C.E., Koprowski H. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J. Hum. Virol. 2000, 3:50-57.
29. Dietzschold B., Schnell M.J. New approaches to the development of live attenuated rabies vaccines. Hybrid. Hybridomics 2002, 21:129-134.
30. Dietzschold B., Wunner W.H., Wiktor T.J., Lopes D., Lafon M., Smith C.L., Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:70-74.
31. Domingo E., Martinez-Salas E., Sobrino F., de la Torre J.C., Portela A., Ortin J., Lopez-Galindez C., Perez-Brena P., Villanueva N., Najera R., et al. The quasispecies (extremely heterologous) nature of viral RNA genome populations: biological relevance-a review. Gene 1985, 49:1-8.
32. Dreesen D.W. A global review of rabies vaccines for human use. Vaccine 1997, 15(Suppl.):S2-S6.
33. Ertl H.C. Rabies DNA vaccines for protection and therapeutic treatment. Expert Opin. Biol. Ther. 2003, 3:639-644.
34. Ertl H.C., Dietzschold B., Otvos L. T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides. Eur. J. Immunol. 1991, 21:1-10.
35. Faber M., Faber M.L., Li J., Preuss M.A., Schnell M.J., Dietzschold B. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. J. Virol. 2007, 81(13):7041-7047.
36. Faber M., Pulmanausahakul R., Nagao K., Prosniak M., Rice A.B., Koprowski H., Schnell M.J., Dietzschold B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16328-16332.
37. Fooks A.R. The challenge of emerging lyssaviruses. Expert Rev. Vaccines 2004, 3(4):89-92.
38. Fooks A.R. Rabies in Europe-editorial. Eurosurveillance 2005, 10(11):1-4.
39. Fooks A.R., McElhinney L.M., Brookes S.B., Johnson N., Keene V., Parsons G., Soldan A. Rabies antibody testing and the UK Pet Travel Scheme. Vet. Rec. 2002, 150:428-430.
40. Fooks A.R., McElhinney L.M., Pounder D., Finnegan C., Mansfield K., Brookes S.M., Parsons G., White K., McIntyre P.G., Nathwani D. Case report: isolation of a European Bat Lyssavirus type-2a from a fatal case of rabies encephalitis. J. Med. Virol. 2003, 71:281-289.
41. Gastka M., Horvath J., Lentz T.L. Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay. J. Gen. Virol. 1996, 77:2437-2440.
42. Goldwasser R.A., Kissling R.E. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc. Soc. Exp. Biol. Med. 1958, 98:219-223.
43. Gomez-Alonso J. Rabies: a possible explanation for the vampire legend. Neurology 1998, 51:856-859.
44. Gould A.R., Hyatt A.D., Lunt R., Kattenbelt J.A., Hengstberger S., Blacksell S.D. Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia. Virus Res. 1998, 54(2):165-187.
45. Hanlon C.A., Kuzmin I.V., Blanton J.D., Weldon W.C., Manangan J.S., Rupprecht C.E. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 2005, 111:44-54.
46. Hattwick M.A., Weis T.T., Strechshulte C.J., Baer G.M., Gregg M.B. Recovery from rabies: a case report. Ann. Intern. Med. 1972, 76:931-942.
47. Hemachuda T. Human rabies: clinical aspects, pathogenesis and potential therapy. Lyssaviruses 1994, 121-143. Springer-Verlag, Berlin. C.E. Rupprecht, B. Dietzschold, H. Kowprowski (Eds.).
48. Hemachuda T. Rabies. Central Nervous System Infectious Diseases and Therapy 1997, 573-600. Marcel Dekker Inc., New York. K.L. Roos (Ed.).
49. Hemachudha T., Mitrabhakdi E., Wilde H., Vejabhuti A., Siripataravanit S., Kingnate D. Additional reports of failure to responds to treatment after rabies exposure in Thailand. Clin. Infect. Dis. 1999, 28:143-144.
50. Hemachuda T., Phuapradit P. Rabies. Curr. Opin. Neurol. 1997, 10:260-267.
51. Hemachudha T., Sunsaneewitayakul B., Desudchit T., Suankratay C., Sittipunt C., Wacharapluesadee S., Khawplod P., Wilde H., Jackson A.C. Failure of therapeutic coma and ketamine for therapy of human rabies. J. Neurovirol. 2006, 12(5):407-409.
52. Holland J.J., de la Torre J.C., Clarke D.K., Duarte E. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 1991, 65:2960-2967.
53. Holmes E.C., Woelk C.H., Kassis R., Bourhy H. Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 2002, 292:247-257.
54. Hooper D.C. The role of immune responses in the pathogenesis of rabies. J. Neurovirol. 2005, 11:88-92.
55. Hooper D.C., Morimoto K., Bette M., Weihe E., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 1998, 72:3711-3719.
56. Jackson A.C., Scott C.A., Owen J., Weli S.C., Rossiter J.P. Therapy with minocycline aggravates experimental rabies in mice. J. Virol. 2007, 81(12):6248-6253.
57. Johnson N., McElhinney L.M., Smith J., Lowings P., Fooks A.R. Phylogenetic comparison of the genus Lyssavirus using distal coding sequences of the glycoprotein and nucleoprotein genes. Arch. Virol. 2002, 147:2111-2123.
58. Johnson N., McKimmie C.S., Mansfield K.L., Wakeley P.R., Brookes S.M., Fazakerley J.K., Fooks A.R. Lyssavirus infection activates interferon gene expression in the brain. J. Gen. Virol. 2006, 87:2663-2667.
59. Johnson N., Phillpotts R., Fooks A.R. Airborne transmission of Lyssaviruses. J. Med. Microbiol. 2006, 55(6):785-790.
60. Johnson N., Wade Lipscombe D., Stott R., Gopal Rao G., Mansfield K., Smith J., McElhinney L.M., Fooks A.R. Investigation of a human case of rabies in the United Kingdom. J. Clin. Virol. 2002, 25:351-356.
61. Kaplan M.M. Safety precautions in handling rabies virus. Laboratory Techniques in Rabies 1996, 3-8. World Health Organization, Geneva. 3rd ed. M.M. Kaplan, H. Kowprowski (Eds.).
62. Kaplan M.M., Cohen D., Koprowski H., Dean D., Ferrigan L. Studies on the local treatment of wounds for the prevention of rabies. Bull. World Health Organ. 1962, 26:765-775.
63. Kissi B., Badrane H., Audry L., Lavenu A., Tordo N., Brahimi M., Bourhy H. Dynamics of rabies virus quasispecies during serial passages in heterologous hosts. J. Gen. Virol. 1999, 80:2041-2050.
64. Kissi B., Tordo N., Bourhy H. Genetic polymorphism in the rabies virus nucleoprotein. Virology 1995, 209:526-537.
65. Koprowski H. The mouse inoculation test. Laboratory Techniques in Rabies 1996, 80-87. World Health Organisation, Geneva. 4th ed. F.X. Meslin, M. Kaplan, H. Koprowski (Eds.).
66. Kuzmin I.V., Hughes G.J., Botvinkin A.D., Orciari L.A., Rupprecht C.E. Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition. Virus Res. 2005, 111:28-43.
67. Kuzmin I.V., Orciari L.A., Arai Y.T., Smith J.S., Hanlon C.A., Kameoka Y., Rupprecht C.E. Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. Virus Res. 2003, 97:65-79.
68. Lafon M. Bat rabies-the Achilles heel of a viral killer?. Lancet 2005, 366:876-877.
69. Langevin C., Jaaro H., Bressanelli S., Fainzilber M., Tuffereau C. Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J. Biol. Chem. 2002, 277:37655-37662.
70. Larghi O.P., Diaz A.M. Cross protection of mice against different rabies virus isolates. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 1985, 259(2):268-274.
71. Lembo T., Haydon D.T., Velasco-Villa A., Rupprecht C.E., Packer C., Brandão P.E., Kuzmin I.E., Fooks A.R., Barrat J., Cleaveland S. Molecular epidemiology identifies only a single rabies virus variant circulating in complex carnivore communities of the Serengeti. Proc. Biol. Sci. 2007, 274(1622):2123-2130.
72. Lentz T.L., Burrage T.G., Smith A.L., Crisk J., Tignor G.H. Is the acetylcholine receptor a rabies virus receptor?. Science 1982, 215:182-184.
73. Leslie M.J., Messenger S., Rohde R.E., Smith J., Cheshier R., Hanlon C., Rupprecht C.E. Bat-associated rabies virus in Skunks. Emerg. Infect. Dis. 2006, 12(8):1274-1277.
74. Lewis P., Fu Y., Lentz T.L. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. Muscle Nerve 2000, 23:720-730.
75. Lewis V.J., Thacker W.L. Limitations of deteriorated tissue for rabies diagnosis. Health Lab. Sci. 1974, 11:8-12.
76. Lord R.D., Fuenzalida E., Delpietro H., Larghi O.P., de Díaz A.M., Lãzaro L. Observations on the epizootiology of vampire bat rabies. Bull. Pan Am. Health Organ. 1975, 9(3):189-195.
77. Lumlertdacha B., Boongird K., Wanghongsa S., Wacharapluesadee S., Chanhome L., Khawplod P., Hemachudha T., Kuzmin I., Rupprecht C.E. Survey for bat lyssaviruses, Thailand. Emerg. Infect. Dis. 2005, 11:232-236.
78. Luo T.R., Minamoto N., Ito H., Goto H., Hiraga S., Ito N., Sugiyama M., Kinjo T. A virus neutralizing eptiope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Res. 1997, 51:35-41.
79. Ma J.K., Chikwamba R., Sparrow P., Fischer R., Mahoney R., Twyman R.M. Plant-derived pharmaceuticals-the road forward. Trends Plant Sci. 2005, 10:580-585.
80. MacInnes C.D., Smith S.M., Tinline R.R., Ayers N.R., Bachmann P., Ball.D.G., Calder L.A., Crosgrey S.J., Fielding C., Hauschilt P., Honig J.M., Johnston D.H., Lawson K.F., Nunan C.P., Pedde M.A., Pond B., Stewart R.B., Voigt D.R. Elimination of rabies from red foxes in eastern Ontario. J. Wildl. Dis. 2001, 37:119-132.
81. Mallawa M., Fooks A.R., Banda D., Chikungwa P., Mankhambo L., Molyneux E., Molyneux M.E., Solomon T. Rabies encephalitis in a malaria-endemic area of Malawi, Africa. Emerg. Infect. Dis. 2007, 13(1):136-139.
82. Mansfield K., McElhinney L.M., Hübschle O., Mettler F., Sabeta C., Nel L.H., Fooks A.R. A molecular epidemiological study of rabies epizootics in Kudu ( Tragelaphus strepsiceros) in Namibia. BMC Vet. Res. 2006, 2:2.
83. Mansfield K.L., Johnson N., Fooks A.R. Identification of a conserved linear epitope at the N terminus of the rabies glycoprotein. J. Gen. Virol. 2004, 85:3279-3283.
84. Marcovistz R., Hovanessian A.G., Tsiang H. Distribution of rabies virus, interferon and interferon-mediated enzymes in the brains of virus-infected rats. J. Gen. Virol. 1984, 65:995-997.
85. Marcovistz R., Leal E.C., Matos D.C., Tsiang H. Interferon production and immune response induction in apathogenic rabies virus-infected mice. Acta Virol. 1994, 38:193-197.
86. Marquette C., Ceccaldi P.-E., Ban E., Weber P., Tsiang H., Haour F. Alteration of interleukin-1 alpha production and interleukin-1 alpha binding sites in mouse brain during rabies infection. Arch. Virol. 1996, 141:573-585.
87. Marston D., McElhiney L.M., Johnson N., Müller T., Conzelmann K.K., Tordo N., Fooks A.R. Comparative analysis of the full genome sequence for European Bat Lyssavirus type-1 and type-2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3′-nontranslated region. J. Gen. Virol. 2007, 88:1302-1314.
88. Matouch O., Jaros J., Pohl P. Survival of rabies virus under external conditions. Vet. Med. 1987, 32(LX):669-674.
89. McColl K.A., Tordo N., Aguilar Setien A.A. Bat lyssavirus infections. Rev. Sci. Tech. 2000, 19:177-196.
90. McGarvey P.G., Hammond J., Dienelt M.M., Hooper D.C., Michaels F.H., Fu Z.F., Dietzschold B., Koprowski H. Expression of the rabies virus glycoprotein in transgenic tomatoes. Bio/Technology 1995, 13:1484-1487.
91. McGettigan J.P., Koser M.L., McKenna P.M., Smith M.E., Marvin J.M., Eisenlohr L.C., Dietzschold B., Schnell M.J. Enhanced humoral HIV-1-specifc immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. Virology 2006, 344:363-377.
92. McKimmie C.S., Johnson N., Brown A.R., Fooks A.R., Fazakerley J.K. Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem. Biophys. Res. Commun. 2005, 336(3):925-933.
93. Meltzer M.I., Rupprecht C.E. A review of the economics of the prevention and control of rabies: part I, global impact and rabies in humans. Pharmacoeconomics 1998, 14:365-383.
94. Meslin F.X., Stohr K. Prospects for immunisation against rabies in developing countries. Rabies Control in Asia 1997, 15-18. Elsevier, Paris. B. Dodet, F.-X. Meslin (Eds.).
95. Messenger S.L., Smith J.S., Rupprecht C.E. Emerging epidemiology of bat-associated cryptic cases of rabies in humans in the United States. Clin. Infect. Dis. 2002, 35:738-747.
96. Morimoto K., Hooper D.C., Carbaugh H., Fu Z., Koprowski H., Dietzschold B. Rabies virus quasispecies: implications for pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3152-3156.
97. Morimoto K., Hooper D.C., Spitsin S., Koprowski H., Dietzschold B. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 1999, 73:510-518.
98. Nel L.H. Vaccines for lyssaviruses other than rabies. Expert Rev. Vaccines 2005, 4:533-540.
99. Nel L.H., Sabeta C.T., von Teichman B., Jaftha J.B., Rupprecht C.E., Bingham J. Mongoose rabies in southern Africa: re-evaluation based on molecular epidemiology. Virus Res. 2005, 109:165-173.
100. Neville J. Chapter 1-rabies in the ancient world. Historical Perspective of Rabies in Europe and the Mediterranean Basin Paris, France, 2004, 1-12. OIE Publications. A.A. King, A.R. Fooks, M. Aubert, A.I. Wanderler (Eds.).
101. Ni Y., Tominga Y., Honda Y., Morimoto K., Sakamoto S., Kawai A. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody Rg719. Microbiol. Immunol. 1995, 39:693-702.
102. Nietfeld J.C., Rakich P.M., Tyler D.E., Bauer R.W. Rabies-like inclusions in dogs. J. Vet. Diag. Invest. 1989, 1:333-338.
103. Pãez A., Saad C., Ñũnez C., Bóshell J. Molecular epidemiology of rabies in northern Colombia 1994-2003. Evidence for human and fox rabies associated with dogs. Epidemiol. Infect. 2005, 133:529-536.
104. Pal S.R., Arora B., Chhuttani P.N., Broor S., Choudhury S., Joshi R.M., Ray S.D. Rabies virus infection of a flying fox bat, Pteropus policephalus in Chandigarh, Northern India. Trop. Geogr. Med. 1980, 32:265-267.
105. Porras C., Barboza J.J., Fuenzalida E., Adaros H.L., Oviedo A.M., Furst J. Recovery from rabies in man. Ann. Intern. Med. 1976, 8:44-48.
106. Prehaud C., Coulon P., Lafay F., Thiers C., Flamand A. Antigenic site II of rabies virus glycoprotein: structure and role in viral virulence. J. Virol. 1988, 62:1-7.
107. Prehaud C., Harris R.D., Fulop V., Koh C.L., Wong J., Flamand A., Bishop D.H. Expression, characterization, and purification of a phosphorylated rabies nucleoprotein synthesized in insect cells by baculovirus vectors. Virology 1990, 178:486-497.
108. Prosniak M., Hooper D.C., Dietzschold B., Koprowski H. Effect of rabies virus infection on gene expression in mouse brain. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:2758-2763.
109. Raux H., Coulon P., Lafay F., Flamand A. Monoclonal antibodies which recognize the acidic configuration of the rabies virus glycoprotein at the surface of the virion can be neutralizing. Virology 1995, 210:400-408.
110. Rodrigues F.M., Mandke V.B., Roumiantzeff M., Rao C.V., Mehta J.M., Pavri K.M., Poonwalla C. Persistence of rabies antibody 5 years after pre-exposure prophylaxis with human diploid cell antirabies vaccine and antibody response to a single booster dose. Epidemiol. Infect. 1987, 99:91-95.
111. Rotz L.D., Hensley J.A., Rupprecht C.E., Childs J.E. Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990-1996). J. Am. Vet. Med. Assoc. 1998, 212:1198-1200.
112. Rudd R.J., Trimarchi C.V. Comparison of sensitivity of BHK-21 and murine neuroblastoma cells in the isolation of a street strain rabies virus. J. Clin. Microbiol. 1987, 25:1456-1458.
113. Rupprecht C.E., Dietzschold B., Wunner W.H., Koprowski H. Antigenic relationships of lyssaviruses. The Natural History of Rabies 1991, 69-100. CRC, Boca Raton, FL. 2nd ed. G.M. Baer (Ed.).
114. Rupprecht C.E., Gibbons R.V. Clinical practice. Prophylaxis against rabies. N. Engl. J. Med. 2004, 351(25):2626-2635.
115. Rupprecht C.E., Hanlon C.A., Hemachudha T. Rabies re-examined. Lancet Infect. Dis. 2002, 2:327-343.
116. Rupprecht C.E., Wiktor T.J., Johnston D.H., Hamir A.N., Dietzschold B., Wunner W.H., Glickman L.T., Koprowski H. Oral immunization and protection of raccoons ( Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl. Acad. Sci. U.S.A. 1986, 8:7947-7950.
117. Sabeta, C., Mansfield, K., McElhinney, L.M., Fooks., A.R. and Nel, L.H. Molecular epidemiology of rabies in bat-eared foxes ( Otocyon megalotis) in South Africa. Virus Res. 2007; 129:1-10.
118. Sacramento D., Bourhy H., Tordo N. PCR technique as an alternative method for diagnosis and molecular epidemiology of rabies virus. Mol. Cell. Probes 1991, 5:229-240.
119. Saha A., Rangarajan P. Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. J. Gen. Virol. 2003, 84:1729-1735.
120. Samaratunga H., Searle J.W., Hudson N. Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat lyssavirus infection (pteropid Lyssavirus) infection. Neoropathol. Appl. Neurobiol. 1998, 24:331-335.
121. Schneider L., Burstler H. Studies on the pathogenesis of rabies in fowls after intracerebral infection. Zentralbl. Veterinarmed B 1967, 14:598-624.
122. Schnell M.J., Mebatsion T., Conzelmann K.K. Infectious rabies viruses from cloned cDNA. EMBO J. 1994, 13:4195-4203.
123. Seif I., Coulon P., Rollin P.E., Flamand A. Rabies virulence: effects on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol. 1985, 53:926-934.
124. Selimov M.A., Mikhailovskii E.M., Gribencha S.V. Epidemiology of rabies in the USSR between 1964 and 1971. Simpozium Po Beshenstvu (Symp. Rabies) 1972, 79-82.
125. Servas V., Mailles A., Neau D., Castor C., Manetti A., Fouquet E., Ragnaud J.-M., Bourhy H., Paty M., Melik N., Astoul J., Cliquet F., Moiton M., Francois C., Coustillas M., Minet J.C., Parriaud P., Capek I., Filleul L. An imported case of canine rabies in Aquitaine: investigation and management of the contacts at risk, August 2004-March 2005. Eurosurveillance 2005, 10(11):222-225.
126. Shill M., Baynes R.D., Miller S.D. Fatal encephalitis despite appropriate post-exposure prophylaxis. A case report. N. Engl. J. Med. 1987, 316:1257-1258.
127. Shope R.E., Murphy F.A., Harrison A.K., Causey O.R., Kemp G.E., Simpson D.I.H., Moore D.L. Two African viruses serologically and morphologically related to rabies virus. J. Virol. 1970, 6:690-692.
128. Slate D., Rupprecht C.E., Rooney J.A., Donovan D., Lein D.H., Chipman R.B. Status of oral rabies vaccination in wild carnivores in the United States. Virus Res. 2005, 111:68-76.
129. Smith J.S. Rabies virus epitopic variation: use in ecologic studies. Adv. Virus Res. 1989, 36:215-307.
130. Smith J., McElhinney L.M., Parsons G., Brink N., Doherty T., Agranoff D., Miranda M.E., Fooks A.R. Case report: rapid antemortem diagnosis of a human case of rabies imported into the UK from the Philippines. J. Med. Virol. 2003, 69:150-155.
131. Smith J.S., Orciari L.A., Yager P.A., Seidel H.D., Warner C.K. Epidemiologic and historical relationships among 87 rabies virus isolates determined by limited sequence analysis. J. Infect. Dis. 1992, 166:296-307.
132. Solomon T., Marston D., MacPherson M., Felton T., Shaw S., McElhinney L.M., Das K., Mansfield K., Wainwright J., Kwong G.N.M., Fooks A.R. Paralytic rabies following a 2 week holiday in India. BMJ 2005, 331:469-470.
133. Srinivasan A., Burton E.C., Kuehnert A.J., Ruprecht C., Sutker W.L., Ksiazek T.G., Paddock C.D., Guarner J., Shieh W.J., Goldsmith C., Hanlon Anlon C.A., Zoretic J., Fischbach B., Niezgoda M., El-Feky W.H., Orciari L., Sanchez E.Q., Likos A., Klintmalm G.B., Cardo D., Leduc J., Chamberland M.E., Jernigan D.B., Zaki S.R. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med. 2005, 352:1103-1111. Rabies in Transplant Recipients Investigation Team.
134. Stewart W.E., Sulkin S.E. Interferon production in hamsters experimentally infected with rabies virus. Proc. Soc. Exp. Biol. Med. 1966, 123:650-654.
135. Sugamata M., Miyazawa M., Mori S., Spangrude G.J., Ewalt L.C., Lodmell D.L. Paralysis of street rabies virus-infected mice is dependent on T-lymphocytes. J. Virol. 1992, 66:1252-1260.
136. Swabe J. Chapter 22-folklore, perceptions, science and rabies. Historical Perspective of Rabies in Europe and the Mediterranean Basin Paris, France, 2004, 311-322. OIE Publications. A.A. King, A.R. Fooks, M. Aubert, A.I. Wanderler (Eds.).
137. Tacal J.V., Boado P.A. Examination for negri bodies of the brains of a species of Philippine bat ( Scotophilus temminckii Horsfield). Acta Med. Philipp. 1966, 3:103-106.
138. Tang X., Luo M., Zhang S., Fooks A.R., Hu R., Tu C. Pivotal role of dogs in rabies transmission, China. Emerg. Infect. Dis. 2005, 11(12):1970-1972.
139. Theerasurakarn S., Ubol S. Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J. Neurovirol. 1998, 4:407-414.
140. Thoulouze M.I., Lafage M., Schachner M., Hartmann U., Cremer H., Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 1998, 72:7181-7190.
141. Tsiang H. Pathophysiology of rabies virus infection of the nervous system. Adv. Virus Res. 1993, 42:375-412.
142. Tuffereau C., Benejean J., Blondel D., Kieffer B., Flamand A. Low-affinity nerve-growth factor receptor (p75NTR) can serve as a receptor for rabies virus. EMBO J. 1998, 17:7250-7259.
143. Turner G.S. Rabies vaccines and interferon. J. Hyg. 1972, 70:445-453.
144. Velasco-Villa A., Orciari L.A., Souza V., JuÃrez-Islas, V., Gomez-Sierra M., Castillo A., Flisser A., Rupprecht C.E. Molecular epizootiology of rabies associated with terrestrial carnivores in Mexico. Virus Res. 2005, 111:13-27.
145. Wandeler A.I., Capt S., Kappeler A., Hauser R. Oral immunization of wildlife against rabies: concept and first field experiments. Rev. Infect. Dis. 1988, 10(Suppl.):S649-S653.
146. Wandeler A.I., Nadin-Davis S.A., Tinline R.R., Rupprecht C.E. Rabies epidemiology: some ecological and evolutionary perspectives. Curr. Top. Microbiol. Immunol. 1994, 187:297-324.
147. Wang Z.W., Sarmento L., Wang Y., Li X.-Q., Dhingra V., Tseggai T., Jiang B., Fu.Z.F. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J. Virol. 2005, 79:12554-12565.
148. Warrell M.J., Warrell D.A. Rabies and other lyssavirus diseases. Lancet 2004, 363:959-969.
149. Wilde H., Sirikawin S., Sabcharoen A., Kingnate D., Tantawichien T., Harischandra P.A., Chaiyabutr N., de Silva D.G., Liyanage J.B., Sitprija V. Failure of postexposure treatment of rabies in children. Clin. Infect. Dis. 1996, 22:228-232.
150. Willoughby R.E. A cure for a rabies?. Sci. Am. 2007, 296:88-95.
151. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., Rupprecht C.E. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 2005, 352:2508-2514.
152. Winkler W.G., Baker E.F., Hopkins C.C. An outbreak of non-bite transmitted rabies in a laboratory animal colony. Am. J. Epidemiol. 1972, 95:267-277.
153. World Health Organization. WHO expert consultation on rabies. WHO technical Report Series 931. 1st report, Geneva, Switzerland, 2005.
154. Wunner W.H., Larson J.K., Dietzschold B., Smith C.L. The molecular biology of rabies viruses. Rev. Infect. Dis. 1988, 10(Suppl. 4):S771-S781.
155. Yarosh O.K., Wanderler A.I., Graham F.L., Campbell J.B., Prevec L. Human adenovirus type 5 vectors expressing rabies glycoprotein. Vaccine 1996, 14:1257-1264.
156. Yusibov V., Modelska A., Steplewski K., Agadjanyan M., Weiner D., Hooper D.C., Koprowski H. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5784-5788.